Cytrellis has launched ellacor® with Micro-Coring Technology in Australia following regulatory approval from the Therapeutic Goods Administration (TGA), expanding access to its non-surgical approach to treating skin laxity and improving skin quality.
Available through exclusive distributor Device Consulting Pty. Ltd., ellacor precisely removes micro-cores of skin while preserving surrounding tissue, triggering the body’s natural healing response and collagen remodeling without surgery, heat or thermal injury.
Get the latest in Medical Aesthetics in our weekly ValuraNova Pulse. Sign up now.
The approval expands ellacor’s use beyond facial rejuvenation to full-body resurfacing, including the neck, abdomen, arms, thighs and knees. The platform is designed to address loose and crepey skin associated with aging, weight loss, pregnancy and other changes, while offering minimal downtime.
The Australian launch reflects growing demand for non-surgical aesthetic treatments that can deliver meaningful skin tightening without the downtime and scarring associated with surgical procedures or the thermal effects of energy-based technologies.
With regulatory access now expanding internationally, Cytrellis is positioning Micro-Coring as a differentiated alternative to traditional skin rejuvenation, extending its platform from facial treatments into a broader full-body aesthetics market.
Read the full story here.
